Thursday, February 22, 2018

Indonesia Pharmaceutical Market will be led by Growing Generic Drugs and Bio-pharmaceutical Market: Ken Research

Expansion of product portfolio by major pharmaceutical companies and increase in demand for generic drugs were the key factors driving growth in Indonesia pharmaceutical Market.
Indonesia healthcare market has observed a favorable growth in the last 5 years. The market is still under penetrated especially in the tier 2 areas in Indonesia as of 2017.
The launch and execution of JKN scheme by the government has led to surge in demand for primary healthcare facilities and increased generic drug sale. The market has underscored various deregulation programs which has stimulated foreign investment in the industry.
Indonesia Pharmaceutical market is dominated by domestic players which controlled majority of the market in 2017. Recent favorable government regulations have facilitated the entry of foreign players in the space. There are 206 pharmaceutical companies (182 domestic and 24 international companies) located in Indonesia.
The market is driven by deregulation in FDI regulations in pharmaceutical and favorable government policies leading to increase in sale of generic drugs. Increased investment in innovation of new drugs with higher margin led to increased profitability of pharmaceutical companies. Expansion of major companies through mergers, acquisitions and alliances has enabled companies to manufacture high end medicines and pharmaceutical products.
The local companies largely focus on generic drugs manufacturing that are dependent on imported active pharmaceutical ingredients (API), mainly from China and India.
As Jaminan Kesehatan Nasional (JKN) has prioritized the use of generic drugs, the demand for unbranded generic drugs has grown as Indonesians increasingly rely on generic drugs. This has augmented the domestic players’ sales. But at the same time, the market has also witnessed an increase in number of new players which has driven down the margins.  Since the product portfolio of majority domestic pharmaceutical companies is dominated by generic drugs, the sales have gone up since 2014. Moreover, the prices of generic drugs are regulated and consistent across Indonesia whereas the prices increase by 10% for branded drugs annually. Domestic players have witnessed success in rural areas of Indonesia. Due to inaccessibility and language barrier existing in the rural areas, the domestic players have been better able to bridge the gap as compared to international players.  The domestic players have also dominated the Over the Counter drugs which are driven by the increasing self medication behavior of the population. Domestic players dominate the Anti-Infectives, Gastrointestinal and metabolism and respiratory therapeutic segments.
Indonesia biopharmaceutical industry is in the nascent stage. There is a strong interest from research-based global biopharma companies to conduct clinical research in Indonesia because of the large concentrated patient populations and disease profiles. Furthermore, as the industry intends to move towards self sufficiency, Indonesian government released the 11th economic stimulus package with the aim of boosting the domestic production of medicines' raw materials, particularly for five product categories namely biotechnology, vaccines, herbal extracts, active pharmaceutical ingredients and medical devices.
In order to tap the existing potential, large domestic pharmaceutical companies have tied up with international players to manufacture biopharmaceutical products for the treatment of chronic diseases such as cancer, kidney failure and others
ProBioGen AG, a CDMO based in Germany, and Bio Farma, a state-owned vaccine manufacturer in Indonesia, has signed an agreement to develop a biosimilar to the monoclonal antibody (mAb) trastuzumab for cancer treatment that will be produced in Indonesia.
Kalbe Farma has also launched biosimilar version of insulin in Indonesia to treat diabetes mellitus which is 38% cheaper than the existing insulin. Biosimilars are cheaper imitations of drugs known as biologics.
Kalbe Farma set up its biological drug factory, PT Kalbio Global Medika in Cikarang, Bekasi, with an investment value that ranges between USD 30 to USD 35 million. The factory is built under the joint venture between Kalbe and a South Korean pharmaceutical company Genexine Inc, PT Kalbe-Genexine Biologics
Key Topics Covered in the Report:
Indonesia Dietary Vitamin Supplements Market
Pharmaceutical Market Size Indonesia
Indonesia Vaccine Market
Indonesia Pharmaceutical Regulations
Number of Pharmaceutical Companies Indonesia
Indonesia Pharmaceutical Market Players
Obese Population Indonesia
Generic Drug Market Size Indonesia
Number of Healthcare Centers in Indonesia
Budget Allocation on Healthcare Indonesia
Healthcare Spending Indonesia
Vitamin and Dietary Supplement Market Indonesia
For more information on the research report, refer to below link:
Related Reports by Ken Research
Contact:         
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-124-4230204

Genetic disorders market is forecast to grow at 13.6% CAGR: Ken Research


Genetic disorders market is forecast to grow from $19.6 billion in 2016 to $47.7 billion in 2023, at a CAGR of 13.6%. This high level of growth will be driven largely by orphan drugs for the treatment of rare genetic disorders. Report titled “Global Genetic Disorders Drugs Market to 2023 - A Rapidly Growing Treatment Landscape Driven by Targeted Complement System Inhibitors and Enzyme Replacement Therapies to Treat PNH and Lysosomal Storage Disease” helps the reader to gain more insights in the area of genetic disorders covering aspects such as Symptoms, Diagnosis, Treatment, Key products, clinical trials, company analysis and future forecast.


As rare genetic disorders are often debilitating or fatal, with low prevalence, sponsors are willing to pay for some of the most expensive treatments in the pharmaceutical industry. This contributes to high sales revenue, despite small patient groups. Orphan drugs are able to generate high revenue because of developmental incentives such as marketing exclusivity, which allows for longer periods before generics and biosimilars can enter the market. Furthermore, other incentives such as tax credits and accelerated approval lower the developmental costs faced by pharmaceutical companies, reducing the inherent financial risks involved and increasing the likelihood of recouping developmental costs from product sales.

The genetic disorders market has a strong presence of specialized companies that focus on the development of treatments for genetic disorders, including Alexion, Sanofi, Shire and Vertex. Treating genetic disorders can be a desirable prospect, as many genetic disorders are underserved – with only symptomatic treatments – allowing for high prices. Furthermore, a range of lucrative incentives such as orphan drug status are available for pharmaceutical companies to develop treatments for rare diseases, including extended periods of market exclusivity and tax credits. There is evidence of more companies moving into this therapy area, and a resultant diversification of market share.

Key Topics Covered in the Report:
Genetic disorders market research report
Genetic disorders treatment market
Genetic disorders medicine market
Genetic disorder cases worldwide
Genetic disorder Drugs Market
G Protein-Coupled Receptor Modulators Market
Metabolic Enzyme Mediators Market
Key Pipeline Products in Genetic Disorders Market
Clinical Trials in Genetic disorder Drugs Market
Soliris (eculizumab) Alexion Market
Orkambi (lumacaftor/ivacaftor) Vertex Market
Pulmozyme (dornase alfa) Roche Market
Duchenne Muscular Dystrophy Treatment Market
Lysosomal Storage Disease Treatment Market
Paroxysmal Nocturnal Hemoglobinuria Treatment Market

To know more about the publication, click on the link below:

Similar Reports:


Contact Us:                                                                                          
Ken Research
Ankur Gupta, Head Marketing & Communications
sales@kenresearch.com
0124-4230204

Huge demand has been observed for steam-sterilised spices and herbs in Europe : Ken Research


The report titled “Herbs, Spices & Seasonings (Seasonings, Dressings & Sauces) Market in Europe-Outlook to 2021: Market Size, Growth and Forecast Analytics”, provides a comprehensive analysis herbs, spices and seasonings market in Europe, European consumers convenience towards easy-to-prepare foods, health awareness, demand for herbs, spices and seasonings, demand for ethnic foods, increasing prices of the herbs, spices and seasonings and future of European herbs, spices and seasonings market.

Industry Overview: Herbs, spices and seasonings are various pungent, aromatic plant substances, dried berries such as cinnamon or clove or nutmeg used as whole or ground and added to food for zest and flavour. They also include all dried herbs but exclude fresh herbs, spices and seasonings. The variants in herbs, spices and seasonings are dried herbs, pepper, salt, salt substitutes, single & other spices, spice mixes. The major distribution channel of the herbs, spices and seasonings in Europe are hypermarkets, supermarkets, convenience stores, department stores, dollar stores, variety store, E-retailers, food specialists, health stores, beauty stores, and other general retailers. European consumers are spending less money and less time on preparing meals due to their busy schedules, also the number of single households is increasing rapidly. Consumers are opting for easy-to-prepare and ready-cooked meals that rely on spices and herbs to retain and enhance food flavour. Easy-to-prepare and ready-cooked meals utilize crushed or ground spices, ground herbs, spice mixtures and herb mixtures that are known as ready-to-use spices and herbs. Therefore, there is a demand for processed spices and herbs and the trend will continue over the next few years. Grinding and crushing with improved processing facilities and detection techniques has witnessed a continuing growth over a period of time.
Unhealthy food ingredients such as salt, sugar and synthetic additives are increasingly replaced by natural ingredients such as spices and herbs to promote healthy living. Consumers are expecting clean labelling and gluten-free labelling in the spices and herbs market. It was observed that there is huge demand for steam-sterilised spices and herbs in Europe because these products meet the strict requirements for microbiological contamination. Consumers earn a small premium, if they use steam sterilisation on spices and herbs.
Growing Demand for Herbs, Spices and Seasonings in Europe: The demand for herbs, spices and seasonings in European is increasing due to the health and wellness trends such as healthy living, interest in new tastes and convenience. European consumers are continuously looking for new suppliers due to high prices and scarcity of herbs, spices and seasonings. European herbs, spices and seasonings market majorly focuses on the special varieties, improved quality and sustainability. However, the new players should comply with strict requirements for quality, food safety and traceability to enter the European herbs, spices and seasonings market. It was observed that for a very long time, Europe imports spices and herbs from the developing countries which is a continuing growth. The maturity of the industrial sector has led to a slower than in other sectors, however, herbs, spices and seasonings market will continue to grow. Almost all the Europe’s herbs, spices and seasonings imports are from the developing countries which hold positive market conditions. Herbs, spices and seasonings market is volume-driven with high competition and low margins. The small and medium-sized enterprises have good opportunities in supplying the speciality spices and herbs that are available and traded in smaller volumes. The special varieties of herbs and spices are Mexican chillies and Tellicherry peppercorns. The vendors focus more on speciality product characteristics such as colour, taste, fineness and sustainability.

Growing Popularity of Ethnic Food in Europe: European consumers are demanding for ethnic food due to growing multicultural population within the country. Therefore, there is a huge demand for spices and herbs which are used in exotic cuisine. The popular flavours and tastes in the exotic cuisine are Chinese (pepper, ginger, anise), Indian food (curry, chillies, cardamom), Thai food (cassia cinnamon, cloves, nutmeg), and Vietnamese cuisine (ginger, chillies, fennel, pepper). The consumers are exploring new tastes by cooks and food manufacturers who ensure the market for herbs, spices and seasonings to grow continuously. Small, large, multinational food retailers and specialized brands are focused on ethnic foods coupled with herbs, spices and seasonings market. Smaller processors, retailers and specialised brands demand less of the herbs, spices and seasonings. Such outlets are less demanding in food safety, service and volume. They often import herbs, spices and seasonings from their home country and it is easy to connect with them. The ethnic food tastes vary by region, country and even consumers due to the use of different ingredients and mixes.

Increase in Prices of Herbs, Spices and Seasonings in Europe: It was observed that there is a trend of increasing prices of herbs, spices and seasonings in the European market due to increasing demand and less production. The country, Madagascar is the leading producer of vanilla and the European import prices of vanilla increased significantly over the recent years due to production problems. The future of herbs, spices and seasonings is questionable due to the supply and huge demand. New plantings of spices and herbs will not be able to satisfy the global demand and replenish the low supply levels. Cultivating spices and herbs is a solution to the scarcity problem and the young population is not interested in farming. Spices and herbs are minor but very important ingredients that contribute taste to the food. Europeans demand for herbs and spices is relatively high and unaffected by price changes.

Way Forward in Herbs, Spices and Seasonings in Europe: European requirements of quality, food safety and sustainability are the strictest in the world. Only a small share of the spice and herb are in compliant with European Union requirements. The increase in prices of herbs and spices has also increased fraud causing major concerns for European buyers. The country is continuously looking for suppliers who can meet the strictest requirements to establish long-term relationships along with reliable stock. Few suppliers work directly with farmers to avoid middlemen and such developments offer opportunities in the supply chain of herbs and spices. Europe herbs and spices consumers are attentive towards the responsibility for the social and environmental impact of the business. They are more concerned about child labour, healthy and safe working conditions, respecting labour laws, paying minimum wage and correct use of pesticides. All the herbs and spices leading players such as Unilever, Olam and Verstegen in Europe are collectively working on making the market more sustainable. European consumers are attracted towards convenience, health awareness, demand for ethnic foods and quality of product which tends drive the growth of herbs, spices and seasonings market in the next few years.

Key Topics Covered in the Report:
Europe Herbs, Spices and Seasonings Market Report
Europe Herbs, Spices and Seasonings Market Analysis
Europe Herbs, Spices and Seasonings Market Outlook
Europe Herbs, Spices and Seasonings Variants Market
Europe Herbs, Spices and Seasonings Variants Market Report
Europe Herbs, Spices and Seasonings Variants Market Analysis
Europe Herbs, Spices and Seasonings Variants Market Outlook
Europe Herbs, Spices and Seasonings Market Growth
Europe Dried Herbs Market Report
Europe Dried Herbs Market Analysis
Europe Dried Herbs Market Outlook
Europe Spice Mixes Market Report
Europe Spice Mixes Market Analysis
Europe Spice Mixes Market Outlook
Europe Herbs, Spices and Seasonings Market Value by Brands
Europe Herbs, Spices and Seasonings Market by Distribution Channel
Germany Herbs, Spices and Seasonings Market
Italy Herbs, Spices and Seasonings Market
Spain Herbs, Spices and Seasonings Market
Germany Herbs, Spices and Seasonings Market
Switzerland Herbs, Spices and Seasonings Market

To know more, click on the link below:

https://www.kenresearch.com/food-beverage-and-tobacco/general-food/herbs-spices--seasonings-seasonings-dressings--sauces-market-europe-outlook-market-size-growth-forecast-analytics/143156-11.html

 

Similar Reports:

Contact Us:                                                                                          
Ken Research
Ankur Gupta, Head Marketing & Communications
sales@kenresearch.com
0124-4230204

Lymphangioleiomyomatosis Global Clinical Trials Review H2 2017: Ken Research

GlobalData'sclinical trial report, Lymphangioleiomyomatosis Global Clinical Trials Review, H2, 2017" provides an overview of Lymphangioleiomyomatosis clinical trials scenario. This report provides top line data relating to the clinical trials on Lymphangioleiomyomatosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using GlobalData'sproprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

The report provides a snapshot of the global clinical trials landscape Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment The Report provides enrollment trends for the past five years Report provides latest news for the past three months

Key Topics Covered in the Report:
Lymphangioleiomyomatosis Global Clinical Trials
Global Lymphangioleiomyomatosis Clinical Trials Market Research Report
Global Lymphangioleiomyomatosis Clinical Trials Market Size
Global Lymphangioleiomyomatosis Clinical Trials Market Share
Global Lymphangioleiomyomatosis Clinical Trials Market Outlook
Global Lymphangioleiomyomatosis Clinical Trials Market Trends
Global Lymphangioleiomyomatosis Clinical Trials Market Volume
Europe Lymphangioleiomyomatosis Clinical Trials Market
US Lymphangioleiomyomatosis Clinical Trials Market Revenue
Global Lymphangioleiomyomatosis Clinical Trials Market Forecast

To know more, click on the link below:

Contact:        
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-124-4230204

Global Lyme Disease Clinical Trials Market Research Report: Ken Research

GlobalData'sclinical trial report, Lyme Disease Global Clinical Trials Review, H2, 2017" provides an overview of Lyme Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Lyme Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using GlobalData'sproprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

The report provides a snapshot of the global clinical trials landscape Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment The Report provides enrollment trends for the past five years Report provides latest news for the past three months

Key Topics Covered in the Report:
Global Lyme Disease Clinical Trials Market Research Report
Global Lyme Disease Clinical Trials Market Size
Global Lyme Disease Clinical Trials Market Outlook
Global Lyme Disease Clinical Trials Market Trends
Global Lyme Disease Clinical Trials Market Volume
Global Lyme Disease Clinical Trials Market Share
Global Lyme Disease Clinical Trials Market Analysis
Global Lyme Disease Clinical Trials Market Growth
Global Lyme Disease Clinical Trials Industry Research
Europe Lyme Disease Clinical Trials Market

To know more, click on the link below:

Contact:        
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-124-4230204

Medical Device Market Indonesia, Medical Device Imports Indonesia, Medical Devices Imports Indonesia : Ken Research


Indonesia Medical device market is almost entirely import driven. The local companies manufacturing is restricted to production of medical consumables and hospital furniture whereas sophisticated medical devices such as diagnostic imaging devices, dental products, orthopedic implants and others are majorly imported from USA, Germany, the Netherlands and Japan.
Indonesia Healthcare market will be facilitated by the rising number of healthcare providers coupled with elevating prevalence of chronic diseases such as diabetes, HIV, Tuberculosis and others. More than 35,000 new beds are likely to be added in Indonesia by 2020.

Prevalence of cardiovascular and oncology diseases coupled with the rising geriatric population base is expected to drive the market for diagnostic imaging products in Indonesia in 2022. Further, investment by international companies along with investment in medical research will bring in advanced devices for better quality of services. The market will witness growing acceptance of 3D imaging techniques among the radiologists and surgeons owing to the benefits such as instrumental manifestations which is not possible with 2D imaging. The imports will increase as demand for advanced clinical laboratory and diagnostics equipment increases which depend heavily on the incidence of diseases related to circulatory problems, diabetes, infections, parasites, and respiratory problems. The government plans to equip community health centers with inpatient facilities and improve their quality of services throughout 34 provinces. This will create further demand for diagnostic imaging devices, auxiliary devices, medical consumables and orthopedic implants in the country.  Aging population is going to impact the demand for orthopedic products and implants and assistive devices market in the positive manner. Rising number of geriatric population will complain about various orthopedic disorders such as arthritis, and osteoporosis, which will subsequently lead to more number of orthopedic procedures, hence elevating the market.
Growing demand for home-use medical devices, expansion of healthcare facilities coupled with rising prevalence of lifestyle and chronic diseases will propel the Indonesia medical device market revenue in future.

Ken Research in its latest study, “Indonesia Medical Devices Market Outlook to 2022 - By Medical Consumable Products, Diagnostic Imaging Products, Auxiliary Devices, Orthopedic Implants, Dental Products, Aesthetic Devices, By Imports & Domestic Production, suggests that demand for medical devices in the market will continue to grow in Indonesia owing to technology advancements and rising number of hospitals and other healthcare facilities.

Key Topics Covered in the Report:
Medical Device Market Indonesia
Medical Consumables Market Indonesia
Type of Medical Devices Indonesia
Medical Device Imports Indonesia
Medical Device Future Trends Indonesia
Trends Indonesia Medical Device Industry
Medical Devices Imports Indonesia
Major Medical Device Manufacturers Indonesia
Major Medical Device Distributors Indonesia
Major International Companies Medical Device Indonesia
Medical Device Competition Parameters
Number of Medical Device Distributors in Indonesia
Type of Medical Consumables in Indonesia
Medical Device Procurement Indonesia
Orthopedic Equipment Market Indonesia
Diagnostic Imaging Industry Indonesia
Medical Consumable Sales Indonesia
Dental Devices Market Indonesia
Competition Orthopedic Devices Indonesia
Market Share Medical Device Indonesia
Future Indonesia Medical Device
Domestic Sales Medical Devices Indonesia
Imported Medical Devices Indonesia
Woundcare Market Indonesia
Syringes, Needles Sales Indonesia
Bandage and Dressings Revenue Indonesia
Suturing Materials Market Indonesia
Ostomy Products Sales Indonesia

For more information on the research report, refer to below link:


Related Reports by Ken Research:


Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
Ankur@kenresearch.com
+91-9015378249